Article
In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer.
Journal of cancer research and clinical oncology - 1 Jan 1998
Perdomo J A, Naomoto Y, Haisa M, Fujiwara T, Hamada M, Yasuoka Y, Tanaka N
Abstract excerpt
Alteration of the p53 gene product is a frequent event in the progression of lung cancer. However, its importance to proliferation and response to chemoradiotherapy remains unclear. Thus, to assess its influence directly in vivo, we implanted into nude mice two kinds of human non-small-cell lung cancer (NSCLC) cells: H226br having a homozygous gene mutation in p53 (mt-p53) and H226b with intact p53 (wt-p53). We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
